Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 127 of 127 entries
Sorted by: Best Match Show Resources per page
An overview of vaccine development for COVID-19.

Therapeutic delivery

Shahcheraghi SH, Ayatollahi J, Aljabali AA, Shastri MD, Shukla SD, Chellappan DK, Jha NK, Anand K, Katari NK, Mehta M, Satija S, Dureja H, Mishra V, Almutary AG, Alnuqaydan AM, Charbe N, Prasher P, Gupta G, Dua K, Lotfi M, Bakshi HA, Tambuwala MM.
PMID: 33624533
Ther Deliv. 2021 Mar;12(3):235-244. doi: 10.4155/tde-2020-0129. Epub 2021 Feb 24.

The COVID-19 pandemic continues to endanger world health and the economy. The causative SARS-CoV-2 coronavirus has a unique replication system. The end point of the COVID-19 pandemic is either herd immunity or widespread availability of an effective vaccine. Multiple...

Cite
Shahcheraghi SH, Ayatollahi J, Aljabali AA, et al. An overview of vaccine development for COVID-19. Ther Deliv. 2021;12(3):235-244doi: 10.4155/tde-2020-0129.
Shahcheraghi, S. H., Ayatollahi, J., Aljabali, A. A., Shastri, M. D., Shukla, S. D., Chellappan, D. K., Jha, N. K., Anand, K., Katari, N. K., Mehta, M., Satija, S., Dureja, H., Mishra, V., Almutary, A. G., Alnuqaydan, A. M., Charbe, N., Prasher, P., Gupta, G., Dua, K., Lotfi, M., Bakshi, H. A., & Tambuwala, M. M. (2021). An overview of vaccine development for COVID-19. Therapeutic delivery, 12(3), 235-244. https://doi.org/10.4155/tde-2020-0129
Shahcheraghi, Seyed H, et al. "An overview of vaccine development for COVID-19." Therapeutic delivery vol. 12,3 (2021): 235-244. doi: https://doi.org/10.4155/tde-2020-0129
Shahcheraghi SH, Ayatollahi J, Aljabali AA, Shastri MD, Shukla SD, Chellappan DK, Jha NK, Anand K, Katari NK, Mehta M, Satija S, Dureja H, Mishra V, Almutary AG, Alnuqaydan AM, Charbe N, Prasher P, Gupta G, Dua K, Lotfi M, Bakshi HA, Tambuwala MM. An overview of vaccine development for COVID-19. Ther Deliv. 2021 Mar;12(3):235-244. doi: 10.4155/tde-2020-0129. Epub 2021 Feb 24. PMID: 33624533; PMCID: PMC7923686.
Copy Download .nbib Format: NLM
Ontogeny of plasma cytokine and chemokine concentrations across the first week of human life.

Cytokine

Smolen KK, Plotkin AL, Shannon CP, Idoko OT, Pak J, Darboe A, van Haren S, Amenyogbe N, Tebbutt SJ, Kollmann TR, Kampmann B, Ozonoff A, Levy O, Odumade OA.
PMID: 34597920
Cytokine. 2021 Dec;148:155704. doi: 10.1016/j.cyto.2021.155704. Epub 2021 Sep 28.

INTRODUCTION/BACKGROUND & AIMS: Early life is marked by distinct and rapidly evolving immunity and increased susceptibility to infection. The vulnerability of the newborn reflects development of a complex immune system in the face of rapidly changing demands during the...

Cite
Smolen KK, Plotkin AL, Shannon CP, et al. Ontogeny of plasma cytokine and chemokine concentrations across the first week of human life. Cytokine. 2021;148:155704doi: 10.1016/j.cyto.2021.155704.
Smolen, K. K., Plotkin, A. L., Shannon, C. P., Idoko, O. T., Pak, J., Darboe, A., van Haren, S., Amenyogbe, N., Tebbutt, S. J., Kollmann, T. R., Kampmann, B., Ozonoff, A., Levy, O., Odumade, O. A. (2021). Ontogeny of plasma cytokine and chemokine concentrations across the first week of human life. Cytokine, 148155704. https://doi.org/10.1016/j.cyto.2021.155704
Smolen, Kinga K, et al. "Ontogeny of plasma cytokine and chemokine concentrations across the first week of human life." Cytokine vol. 148 (2021): 155704. doi: https://doi.org/10.1016/j.cyto.2021.155704
Smolen KK, Plotkin AL, Shannon CP, Idoko OT, Pak J, Darboe A, van Haren S, Amenyogbe N, Tebbutt SJ, Kollmann TR, Kampmann B, Ozonoff A, Levy O, Odumade OA. Ontogeny of plasma cytokine and chemokine concentrations across the first week of human life. Cytokine. 2021 Dec;148:155704. doi: 10.1016/j.cyto.2021.155704. Epub 2021 Sep 28. PMID: 34597920; PMCID: PMC8665647.
Copy Download .nbib Format: NLM
Venous thromboembolism and major bleeding in patients with COVID-19: A nationwide population-based cohort study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Dalager-Pedersen M, Lund LC, Mariager T, Winther R, Hellfritzsch M, Larsen TB, Thomsen RW, Johansen NB, Søgaard OS, Nielsen SL, Omland L, Lundbo LF, Israelsen SB, Harboe ZB, Pottegård A, Nielsen H, Bodilsen J.
PMID: 33400771
Clin Infect Dis. 2021 Jan 05; doi: 10.1093/cid/ciab003. Epub 2021 Jan 05.

BACKGROUND: Venous thromboembolism (VTE) is a potentially fatal complication of SARS-CoV-2 infection and thromboprophylaxis should be balanced against risk of bleeding. This study aimed to examine risks of VTE and major bleeding in hospitalized and community-managed SARS-CoV-2 patients compared...

Cite
Dalager-Pedersen M, Lund LC, Mariager T, et al. Venous thromboembolism and major bleeding in patients with COVID-19: A nationwide population-based cohort study. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab003.
Dalager-Pedersen, M., Lund, L. C., Mariager, T., Winther, R., Hellfritzsch, M., Larsen, T. B., Thomsen, R. W., Johansen, N. B., Søgaard, O. S., Nielsen, S. L., Omland, L., Lundbo, L. F., Israelsen, S. B., Harboe, Z. B., Pottegård, A., Nielsen, H., & Bodilsen, J. (2021). Venous thromboembolism and major bleeding in patients with COVID-19: A nationwide population-based cohort study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab003
Dalager-Pedersen, Michael, et al. "Venous thromboembolism and major bleeding in patients with COVID-19: A nationwide population-based cohort study." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab003
Dalager-Pedersen M, Lund LC, Mariager T, Winther R, Hellfritzsch M, Larsen TB, Thomsen RW, Johansen NB, Søgaard OS, Nielsen SL, Omland L, Lundbo LF, Israelsen SB, Harboe ZB, Pottegård A, Nielsen H, Bodilsen J. Venous thromboembolism and major bleeding in patients with COVID-19: A nationwide population-based cohort study. Clin Infect Dis. 2021 Jan 05; doi: 10.1093/cid/ciab003. Epub 2021 Jan 05. PMID: 33400771; PMCID: PMC7929126.
Copy Download .nbib Format: NLM
Comorbidity increases the risk of invasive meningococcal disease in adults.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Lundbo LF, Harboe ZB, Sandholdt H, Smith-Hansen L, Valentiner-Branth P, Hoffmann S, Benfield T.
PMID: 34569601
Clin Infect Dis. 2021 Sep 27; doi: 10.1093/cid/ciab856. Epub 2021 Sep 27.

BACKGROUND: Risk of invasive meningococcal disease (IMD) is increased in patients with complement deficiency and HIV infection. Risk associated with comorbidity is not well described.METHODS: Nationwide adult case-control study. Cases for the period 1977-2018 were identified by the national...

Cite
Lundbo LF, Harboe ZB, Sandholdt H, et al. Comorbidity increases the risk of invasive meningococcal disease in adults. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab856.
Lundbo, L. F., Harboe, Z. B., Sandholdt, H., Smith-Hansen, L., Valentiner-Branth, P., Hoffmann, S., & Benfield, T. (2021). Comorbidity increases the risk of invasive meningococcal disease in adults. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab856
Lundbo, Lene Fogt, et al. "Comorbidity increases the risk of invasive meningococcal disease in adults." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab856
Lundbo LF, Harboe ZB, Sandholdt H, Smith-Hansen L, Valentiner-Branth P, Hoffmann S, Benfield T. Comorbidity increases the risk of invasive meningococcal disease in adults. Clin Infect Dis. 2021 Sep 27; doi: 10.1093/cid/ciab856. Epub 2021 Sep 27. PMID: 34569601.
Copy Download .nbib Format: NLM
Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus.

Journal of neurology

Lauvsnes MB, Zetterberg H, Blennow K, Kvaløy JT, Tjensvoll AB, Maroni S, Beyer MK, Greve OJ, Kvivik I, Alves G, Gøransson LG, Harboe E, Hirohata S, Omdal R.
PMID: 34800169
J Neurol. 2021 Nov 20; doi: 10.1007/s00415-021-10893-z. Epub 2021 Nov 20.

BACKGROUND: Neuropsychiatric manifestations (NP) are common in systemic lupus erythematosus (SLE). However, the pathophysiological mechanisms are not completely understood. Neurofilament light protein (NfL) is part of the neuronal cytoskeleton. Increased NfL concentrations, reflecting neurodegeneration, is observed in cerebrospinal fluid...

Cite
Lauvsnes MB, Zetterberg H, Blennow K, et al. Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus. J Neurol. 2021;doi: 10.1007/s00415-021-10893-z.
Lauvsnes, M. B., Zetterberg, H., Blennow, K., Kvaløy, J. T., Tjensvoll, A. B., Maroni, S., Beyer, M. K., Greve, O. J., Kvivik, I., Alves, G., Gøransson, L. G., Harboe, E., Hirohata, S., & Omdal, R. (2021). Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus. Journal of neurology, . https://doi.org/10.1007/s00415-021-10893-z
Lauvsnes, Maria Boge, et al. "Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus." Journal of neurology vol. (2021). doi: https://doi.org/10.1007/s00415-021-10893-z
Lauvsnes MB, Zetterberg H, Blennow K, Kvaløy JT, Tjensvoll AB, Maroni S, Beyer MK, Greve OJ, Kvivik I, Alves G, Gøransson LG, Harboe E, Hirohata S, Omdal R. Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus. J Neurol. 2021 Nov 20; doi: 10.1007/s00415-021-10893-z. Epub 2021 Nov 20. PMID: 34800169.
Copy Download .nbib Format: NLM
Subduction history of the Caribbean from upper-mantle seismic imaging and plate reconstruction.

Nature communications

Braszus B, Goes S, Allen R, Rietbrock A, Collier J, Harmon N, Henstock T, Hicks S, Rychert CA, Maunder B, van Hunen J, Bie L, Blundy J, Cooper G, Davy R, Kendall JM, Macpherson C, Wilkinson J, Wilson M.
PMID: 34244511
Nat Commun. 2021 Jul 09;12(1):4211. doi: 10.1038/s41467-021-24413-0.

The margins of the Caribbean and associated hazards and resources have been shaped by a poorly understood history of subduction. Using new data, we improve teleseismic P-wave imaging of the eastern Caribbean upper mantle and compare identified subducted-plate fragments...

Cite
Braszus B, Goes S, Allen R, et al. Subduction history of the Caribbean from upper-mantle seismic imaging and plate reconstruction. Nat Commun. 2021;12(1):4211doi: 10.1038/s41467-021-24413-0.
Braszus, B., Goes, S., Allen, R., Rietbrock, A., Collier, J., Harmon, N., Henstock, T., Hicks, S., Rychert, C. A., Maunder, B., van Hunen, J., Bie, L., Blundy, J., Cooper, G., Davy, R., Kendall, J. M., Macpherson, C., Wilkinson, J., & Wilson, M. (2021). Subduction history of the Caribbean from upper-mantle seismic imaging and plate reconstruction. Nature communications, 12(1), 4211. https://doi.org/10.1038/s41467-021-24413-0
Braszus, Benedikt, et al. "Subduction history of the Caribbean from upper-mantle seismic imaging and plate reconstruction." Nature communications vol. 12,1 (2021): 4211. doi: https://doi.org/10.1038/s41467-021-24413-0
Braszus B, Goes S, Allen R, Rietbrock A, Collier J, Harmon N, Henstock T, Hicks S, Rychert CA, Maunder B, van Hunen J, Bie L, Blundy J, Cooper G, Davy R, Kendall JM, Macpherson C, Wilkinson J, Wilson M. Subduction history of the Caribbean from upper-mantle seismic imaging and plate reconstruction. Nat Commun. 2021 Jul 09;12(1):4211. doi: 10.1038/s41467-021-24413-0. PMID: 34244511; PMCID: PMC8270990.
Copy Download .nbib Format: NLM
Evolution of Obstructive Lung Function in Advanced Pulmonary Arterial Hypertension.

American journal of respiratory and critical care medicine

Rahaghi FN, Trieu M, Shaikh F, Abtin F, Diaz AA, Liang LL, Barjaktarevic I, Channick RN, San José Estépar R, Washko GR, Saggar R.
PMID: 34555310
Am J Respir Crit Care Med. 2021 Dec 15;204(12):1478-1481. doi: 10.1164/rccm.202105-1169LE.

No abstract available.

Cite
Rahaghi FN, Trieu M, Shaikh F, et al. Evolution of Obstructive Lung Function in Advanced Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2021;204(12):1478-1481doi: 10.1164/rccm.202105-1169LE.
Rahaghi, F. N., Trieu, M., Shaikh, F., Abtin, F., Diaz, A. A., Liang, L. L., Barjaktarevic, I., Channick, R. N., San José Estépar, R., Washko, G. R., & Saggar, R. (2021). Evolution of Obstructive Lung Function in Advanced Pulmonary Arterial Hypertension. American journal of respiratory and critical care medicine, 204(12), 1478-1481. https://doi.org/10.1164/rccm.202105-1169LE
Rahaghi, Farbod N, et al. "Evolution of Obstructive Lung Function in Advanced Pulmonary Arterial Hypertension." American journal of respiratory and critical care medicine vol. 204,12 (2021): 1478-1481. doi: https://doi.org/10.1164/rccm.202105-1169LE
Rahaghi FN, Trieu M, Shaikh F, Abtin F, Diaz AA, Liang LL, Barjaktarevic I, Channick RN, San José Estépar R, Washko GR, Saggar R. Evolution of Obstructive Lung Function in Advanced Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2021 Dec 15;204(12):1478-1481. doi: 10.1164/rccm.202105-1169LE. PMID: 34555310.
Copy Download .nbib Format: NLM
Showing 121 to 127 of 127 entries